Supply Disruption - Ezetimibe with Simvastatin 10/80 mg (Zimybe)

Kia ora,

RE: Supply Disruption - Ezetimibe with Simvastatin 10/80 mg combination tablet (Zimybe)

Due to a delay at the manufacturing site, there is a supply issue affecting Ezetimibe with Simvastatin 10/80 mg (Zimybe).

From 1 June 2026 Pharmac will fund an alternative product Ezetimibe with Simvastatin 10/80 mg (Vytorin). This is not a Medsafe approved product and should be prescribed and supplied in line with Section 29A of the Medicines Act.

Further information, including resupply time frames of the Medsafe approved product will be added to our webpage as updates become available  Ezetimibe with simvastatin (Zimybe) 10/80 mg: Supply issue. 

Please share this information:

Please share this information with your colleagues and within your networks.

If you have any questions regarding this supply issue, please contact enquiry@pharmac.govt.nz.

Ngā mihi,

Felicity | Senior Implementation Advisor

Pharmac | Te Pātaka Whaioranga | PO Box 10 254 | Level 9, 40 Mercer Street, Wellington

P: 0800 660 050 | www.pharmac.govt.nz